Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2018

View Archived Issues

Retinoic acid has role in fragile X

RNA delivery improves CF symptoms

miRNA-126 and miRNA-223 found significantly increased in cardiac sarcoidosis

Hypermethylation variant silences BRCA1 gene

Upregulation of transgelin-2 by KRAS gene mutation contributes to pancreatic cancer development

Almac, Elasmogen and Innovate UK to develop VNAR-based oncology platform

Final results from PROPEL study support further clinical development of PTG-100 in UC

MediciNova, University of Cambridge to study ibudilast in degenerative cervical myelopathy

Researchers discover potent and selective histone deacetylase 11 inhibitors

First patient treated in phase I of HPN-424 in metastatic castration-resistant prostate cancer

Ovid Therapeutics reports topline data from STARS study in Angelman syndrome

Topical curcumin nanocarriers provide retinal protection in preclinical eye disease models

Aevitas Therapeutics, University of Pennsylvania enter sponsored research agreement

Mebias Discovery patents new compounds for pain

Lundbeck's Lu-AF82422 for Parkinson's enters the clinic

Japanese researchers synthesize new analgesic drugs

Angiochem reaches agreement on design of phase III study of ANG-1005

Novel long-range PCR method allows Ebola virus genome sequencing from ecological or clinical samples

NanoViricides' topical dermal shingles drug candidates show efficacy in rat model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...